Innovative original drug Jierun ®, Xirun ® listed in China
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
public data show that China has a high number of patients with COPD and a low rate of disease awareness, with 13.7% of the population aged 40 and over, an increase of 67% in a decadeaccording tostatistics, the number of patients with coping with coping with the lungs in China is nearly 100 million, of which only 2.6% are aware of their own diseasesRecently, two of the world's leading innovativedrug(http://Jierun ® (Jandatro/Glund Ammonium Bromton), and Xirun ® (Gross Bromamium) are listed in China asfor theof inhalants
(http:// of inhalants for the treatment of chronic obstructive pulmonary disease in adultsthese two products and the listed Anrun ® (Malay acid da tro) together to form a full range of slow-resisting lung product line, can be more accurately applied to the most suitable group of COPD patients, these three drugs by NovartisPharmaceutical(http://production, Hanyu Pharmaceuticalis is responsible for the exclusive national promotionIt is understood that the Anrun ® (Malay acid datero) has been included in China's medical insurance drug use, the listing of the Xirun ® (Grun ammonium bromide), Jierun ® (Yodatro / Glund Bromide ammonium) two inhalant products are also actively applying to enter the national health insurance drug catalog
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
